{{Rsnum
|rsid=1799999
|Gene=PPP1R3A
|Chromosome=7
|position=113878379
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=T
|GMAF=0.2911
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=PPP1R3A
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 87.6 | 12.4 | 0.0
| HCB | 7.3 | 43.8 | 48.9
| JPT | 15.9 | 33.6 | 50.4
| YRI | 59.2 | 34.7 | 6.1
| ASW | 71.9 | 24.6 | 3.5
| CHB | 7.3 | 43.8 | 48.9
| CHD | 4.6 | 43.1 | 52.3
| GIH | 37.6 | 50.5 | 11.9
| LWK | 81.8 | 17.3 | 0.9
| MEX | 58.6 | 32.8 | 8.6
| MKK | 86.5 | 13.5 | 0.0
| TSI | 84.3 | 14.7 | 1.0
| HapMapRevision=28
}}{{omim
|desc=INSULIN RESISTANCE, SUSCEPTIBILITY TO
|id=600917
|rsnum=1799999
|variant=0001
}}

{{ neighbor
| rsid = 2974938
| distance = 68
}}

{{ClinVar
|rsid=1799999
|Reversed=1
|FwdREF=G
|FwdALT=T
|REF=C
|ALT=A
|RSPOS=113518434
|CHROM=7
|GMAF=0.2917
|dbSNPBuildID=89
|SSR=0
|SAO=1
|VP=0x05016800000015051f110100
|GENEINFO=PPP1R3A:5506
|GENE_NAME=PPP1R3A
|GENE_ID=5506
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000007.13:g.113518434C>A
|CLNORIGIN=1
|CLNSIG=255
|Tags=RV;PM;PMC;SLO;VLD;G5;HD;GNO;KGPhase1;KGPilot123;KGPROD;OTHERKG;PH3;LSD;OM
|CAF=0.7089; 0.2911
|CLNACC=RCV000009243.1
|CLNDBN=Insulin resistance, susceptibility to
|CLNDSDB=MedGen
|CLNDSDBID=C1852091
|CLNSRC=OMIM Allelic Variant
|CLNSRCID=600917.0001
|COMMON=1
|Disease=Insulin resistance
}}

{{PMID Auto
|PMID=18853455
|Title=Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease.
|OA=1
}}

{{GET Evidence
|gene=PPP1R3A
|aa_change=Asp905Tyr
|aa_change_short=D905Y
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1799999
|overall_frequency_n=1452
|overall_frequency_d=10756
|overall_frequency=0.134994
|n_genomes=17
|n_genomes_annotated=0
|n_haplomes=25
|n_articles=0
|n_articles_annotated=0
|nblosum100=7
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=23133645
|Title=The Interactive Effect of SIRT1 Promoter Region Polymorphism on Type 2 Diabetes Susceptibility in the North Indian Population
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}